- Work address
-
C. Heymanslaan 10, ingang 22 - verdieping 2
9000 Gent - Joline.Ingels@UGent.be
- ORCID iD
-
0000-0001-7030-0373
Show
Sort by
-
Knocking out CD70 rescues CD70-specific nanoCAR T cells from antigen induced exhaustion
(2023) -
- Journal Article
- A1
- open access
Single-cell profiling identifies a novel human polyclonal unconventional T cell lineage
-
- Journal Article
- A1
- open access
Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials
-
- Journal Article
- A1
- open access
Dendritic cell-based immunotherapy in lung cancer
-
- Journal Article
- A1
- open access
In vitro OP9-DL1 co-culture and subsequent maturation in the presence of IL-21 generates tumor antigen-specific T cells with a favorable less-differentiated phenotype and enhanced functionality
-
Treatment of a patient with severe cytomegalovirus (CMV) infection after haploidentical stem cell transplantation with donor-derived CMV-specific T cells
-
- Journal Article
- A1
- open access
Human thymic CD10+ PD-1+ intraepithelial lymphocyte precursors acquire interleukin-15 responsiveness at the CD1a– CD95+ CD28– CCR7– developmental stage
-
- Journal Article
- A1
- open access
Rapid and effective generation of nanobody based CARs using PCR and Gibson Assembly
-
- Journal Article
- A1
- open access
T-cells with a single tumor antigen-specific T-cell receptor can be generated in vitro from clinically relevant stem cell sources
-
An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA loaded dendritic cells for cancer vaccination